Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,361 public trials 354 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

NCT00930553

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Barrow Neurology Clinics - Barrow Neurological Institute Phoenix, Arizona, United States
  • Mayo Clinic Arizona (Scottsdale) Scottsdale, Arizona, United States
View all 176 locations
View Trial Details
Completed

Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex

NCT01864148

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • North Central Neurology Assoc PC Cullman, Alabama, United States
  • Phoenix Neurological Associates Phoenix, Arizona, United States
  • Raleigh Neurology Associates PA Raleigh, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 72 locations
View Trial Details
Completed

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

NCT00094172

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Keck School of Medicine Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Yale MS Research Center New Haven, Connecticut, United States
View all 14 locations
View Trial Details

Related conditions